Interleukin-2 (Aldesleukin) Clinical Trials

1 actively recruiting trial

Also known as: 1.5MIU, 2.0MIU

Top Sponsors

Cambridge University Hospitals NHS Foundation Trust1

Indications

CABG1
Myocardial Infarction (MI)1
Heart Disease1
Coronary Artery Disease1

Other1 trial

Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.